http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN...
Prescription and OTC Drug Product List 10/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
Galderma September 25, 2003-- - Acne Rosacea Skin Care Topical Steroids Hair & Scalp Acne Acne is one of the most common of all skin problems
Galderma September 25, 2003-- - Acne Rosacea Skin Care Topical Steroids Hair & Scalp Clindagel ™ Product Insert Information Clindagel ™ (clindamycin phosphate gel) topical gel, 1% For External Use Rx Only DESCRIPTION: Clindagel ™ (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a...
Galderma NEWS FROM THE ACNE FRONT: GALDERMA INTRODUCES CLINDAGEL ™ (clindamycin phosphate gel) topical gel, 1% FtClindagel ™ (clindamycin phosphate gel) topical gel, 1%
Galderma September 25, 2003-- - Our History Our Focus Research & Development The Future News News About BACK-TO-SCHOOL STRESS and ACNE Learn To Take Charge Of Your Skin Before Stress Takes Over It's that time of year again
(clindamycin phosphate gel) topical gel, 1% NDA 50- 782 Page 3 For External Use DESCRIPTION Tradename (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene glycol 400, propylene glycol, sodium hydroxide, and purified water
author: CDER USER
(clindamycin phosphate gel) topical gel, 1% page 9
author: CDER USER
(clindamycin phosphate gel) topical gel, 1% page 8
author: CDER USER
(clindamycin phosphate gel) topical gel, 1% page 7
author: CDER USER
(clindamycin phosphate gel) topical gel, 1% page 5
author: CDER USER
(clindamycin phosphate gel) topical gel, 1% page 7
author: CDER USER
duplicates:http://www.fda.gov/cder/foi/appletter/2000/50782LTR-LBL.PDF
Drug Approvals - D ANDA 74-904 7/14/98 7/14/98 - 3/16/99 Desoxyn (methamphetamine HCl) Tablets and Desoxyn (methamphetamine HCl) Gradumet Tablets, 5 mg & 5 mg, 10 mg, and 15 mg, Rx- Abbott Laboratories NDA 5-378/S-020 12/6/01 4/3/03 Detrol LA Extended- Release Capsules, Rx Pharmacia and Upjohn NDA 21-228 /S5 1/15 /04 1/22/04 - Detrol LA Extended- Release Capsules, Rx Pharmacia and Upjohn NDA 21-228 /S4...
What's new at CDER by Date - U.S
author: Paul Stauffer
FACT SHEET Stability Time for Maxipime Admixture and IV Infusion RT/ L Refrigeration Concentration Concentration Solutions (20°TH 25° C) (2°TH 8° C) 40 mg/ mL Amikacin NS or D5W 24 hours 7 days 6 mg/ mL 40 mg/ mL Ampicillin D5W 8 hours 8 hours 1 mg/ mL 40 mg/ mL Ampicillin D5W 2 hours 8 hours 10 mg/ mL 40 mg/ mL Ampicillin NS 24 hours 48 hours 1 mg/ mL 40 mg/ mL Ampicillin...
author: K. Notarianni
FACT SHEET page 6
author: K. Notarianni
duplicates:http://www.elan.com/Images/Maxipime_PI_200204_tcm3-4348.pdf
MAX0173 Full PI-4 pager Stability Time for Maxipime Admixture and IV Infusion RT/ L Refrigeration Concentration Concentration Solutions (20°TH 25° C) (2°TH 8° C) 40 mg/ mL Amikacin NS or D5W 24 hours 7 days 6 mg/ mL 40 mg/ mL Ampicillin D5W 8 hours 8 hours 1 mg/ mL 40 mg/ mL Ampicillin D5W 2 hours 8 hours 10 mg/ mL 40 mg/ mL Ampicillin NS 24 hours 48 hours 1 mg/ mL 40 mg/ mL Ampicillin...
author: Freelance
CDER Guidance Documents (Issued 8/2000, Posted 8/8/2000) Joint Safety/Efficacy (Multidisciplinary) (Draft) Submitting Marketing Applications According to the ICH/CTD Format: General Considerations (Issued 9/2001, Posted 9/5/2001) [ PDF ] M4 Common Technical Document--Quality: Questions and Answers/Location Issues [ HTML ] or [ PDF ] or [ ] (Issued 9/12/2002, Posted 12/30/2002) Quality Q1E Evaluation of...
Sep Xs 16-3D.qxd Separation of Lincomycin and Clindamycin - Scaling Up to Short Analytical Column Using Volatile Mobile Phase Column: ZORBAX StableBond C18 4.6 x 50 mm, 5 µm Part Number: 846975- 902 Mobile Phase: Gradient: 0 to 40% B in 5 min Detection: UV 210 nm A: Water w/ 0.2% Formic Acid B: ACN w/ 0.2% Formic Acid Flow Rate: 1.0 mL/ min Injection Volume: 10 µL Temperature: Ambient...
author: j
E:\cleocin labels\Antibact resist AP.doc DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 NDA 50- 162/ S- 084 NDA 50- 441/ S- 048 NDA 50- 639/ S- 014 Pharmacia and Upjohn Company A subsidiary of Pfizer, Inc
author: Judit Milstein
E:\cleocin labels\Antibact resist AP.doc page 1
author: Judit Milstein
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt OF IRELAND" 13266 05-Oct-98 FABBRICA ITALIANA SINTETICI SPA "NITROFURANTOIN MONHYDRATE, MANUFACTURED IN VICENZA, ITALY" 13277 22-Oct-98 MATRIX LABORATORIES LIMITED "ACYCLOVIR USP, MANUFACTURED IN ANDHRA PRADESH, INDIA" 13279 19-Oct-98 SYLACHIM DIV FINORGA "LEVOBETAXOLOL HYDROCHLORIDE, MANUFACTURED IN CHASSE-SUR-RHONE, FRANCE" 13282 15-Oct-98 DAICEL CHEMICAL INDUSTRIES LTD "CHIRALPAK...
Reference Listed Drug Labeling Approved in November 2001 Nov 1 COREG letter ---- carvedilol tablets 20-297 S-007 INDERIDE LA letter label propranolol HCl/HCTZ extended-release capsules 19-059 S-016 INDERIDE letter label propranolol HCl/HCTZ tablets 18-031 S-030 Nov 5 TAMIFLU letter label oseltamivir phosphate suspension oseltamivir phosphate capsules 21-246 21-087 S-004 S-009 Nov 7 REGLAN letter label metoclopramide HCl solution...
author: USERNAME
Prescription and Over-the-Counter Drug Product List: 8/2003 4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR
ANDAs Approvals - May 2000 Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Office Of Generic Drugs ANDAs Approvals May 2000 - 1
author: USERNAME
